Company intelligence / Profile preview

Proclaim

Ownership: Private
Development stage: Commercial

Overview

Proclaim has developed a 3D printed mouthpiece-based oral health system that uses 60 jets of pressurized water to clean teeth and gums. Clinical data cited by the company claims it reduces gum bleeding 10x more effectively than brushing alone and nearly 13x more effective for reducing gum inflammation compared to daily brushing and string flossing[3].

Therapeutic areas: OtherCardiovascularImmunologyHematology
Modalities: Device
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

Proclaim XR

Commercial

Indications: Chronic pain of the trunk and limbs

Beyond the preview

Go deeper on Proclaim.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proclaim.

Explore the full profile